Duloxetine

Product manufactured by Remedyrepack Inc.

Application Nr Approved Date Route Status External Links
ANDA090778 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Duloxetine Delayed-Release Capsules Are Indicated For The Treatment Of: Major Depressive Disorder [See Clinical Studies (14.1) ] Generalized Anxiety Disorder [See Clinical Studies (14.2) ] Diabetic Peripheral Neuropathy [See Clinical Studies (14.3) ] Chronic Musculoskeletal Pain [See Clinical Studies (14.5) ] Duloxetine Delayed-Release Capsules Are A Serotonin And Norepinephrine Reuptake Inhibitor (Snri) Indicated For: Major Depressive Disorder (Mdd) ( 1 ) Generalized Anxiety Disorder (Gad) ( 1 ) Diabetic Peripheral Neuropathic Pain (Dpnp) ( 1 ) Chronic Musculoskeletal Pain ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Duloxetine Hydrochloride DULOXETINE HYDROCHLORIDE ZINC1536779

Comments